ALFA FinderBSE filing, NSE: RAMAVISION. Summary written from the filing by ALFA Finder's alert engine.
Rama Vision Ltd: key numbers
- Share price
- ₹212.30
- Market cap
- ₹221.3 Cr
- Revenue (annual)
- ₹158.8 Cr
- Net profit (annual)
- ₹5.92 Cr
- P/E (TTM)
- 28.4×Sector 46.8×
- Promoter holding
- 54.73%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rama Vision Ltd
All →Rama Vision Q2 FY27 Results: Net Profit ₹2.5 Cr, Up 56.2% YoY
Rama Vision Ltd reported standalone unaudited financial results for the quarter ended September 30, 2026. Revenue from operations reached Rs. 59.57 Crore with a net profit of Rs. 2.45 Crore.
- Key figure
- Net profit ₹2.5 Cr · +56.2% YoY
Rama Vision Board Meeting Date
Rama Vision will hold a board meeting on November 3, 2026 to consider standalone unaudited results for Q2 and H1 FY27. The trading window stays closed until 48 hours after the results are declared.
Rama Vision Other Announcement
Rama Vision Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing includes an update regarding a change in promoter group.
Rama Vision Annual General Meeting
Rama Vision Limited held its 37th Annual General Meeting on September 25, 2026. The meeting covered ordinary business and specific resolutions regarding director remuneration and designations.
Rama Vision Management Change
Mr. Anil Clementa M has resigned as National Sales Manager - Food (Maddox), designated as Senior Management Personnel, effective September 02, 2026.
Rama Vision Annual General Meeting
Rama Vision Limited will hold its 37th Annual General Meeting on September 25, 2026. The company has announced book closure dates and e-voting details.
Other product launch announcements
All →Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.